ISPC vs MXCT: stock comparison and AI forecast
Ispecimen Inc. (ISPC) and Maxcyte, Inc. (MXCT) compared on price performance, valuation, profitability and the daily AI forecast. · Alpha · vs market
Share
ISPC Ispecimen Inc.
- Market Cap
- $2M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
MXCT Maxcyte, Inc.
- Price
- $1.26 +44.5% · 6M
- Market Cap
- $130M
- P/E Ratio
- –
- Size
- small-cap
- AI Forecast
Which one does the AI model favor?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
Key facts
- MXCT is 63.7 times larger than ISPC by market capitalization ($130M against $2M).
- ISPC carries 3.26 times debt per unit of equity, against 0.16 times for MXCT.
- Both companies share the SEC industry classification Services-Commercial Physical & Biological Research.
Fundamentals side by side
Trailing twelve months.
Valuation & Market
| Metric | ISPC | MXCT |
|---|---|---|
| Market Cap | $2M | $130M |
| P/B Ratio | 1.17x | 0.82x |
| EPS | $-43.64 | $-0.38 |
| Book Value/Share | $0.69 | $1.54 |
| Revenue/Share | – | $0.30 |
| FCF/Share | – | $-0.23 |
Profitability & Margins
| Metric | ISPC | MXCT |
|---|---|---|
| ROE | – | -22.4% |
| ROA | – | -19.3% |
| ROIC | – | -23.9% |
| Gross Margin | -175.7% | 79.2% |
| Operating Margin | -1641.2% | -134.6% |
| Net Margin | – | -114.8% |
| EBT Margin | -1291.7% | -114.8% |
Financial Health
| Metric | ISPC | MXCT |
|---|---|---|
| Current Ratio | 0.82x | 12.26x |
| Quick Ratio | – | 11.47x |
| D/E Ratio | 3.26x | 0.16x |
| Financial Leverage | 4.26x | 1.16x |
| Interest Coverage | -1452.9x | -818.0x |
| Working Capital | -$990K | $111M |
Cash Flow
| Metric | ISPC | MXCT |
|---|---|---|
| Operating Cash Flow | -$11M | -$23M |
| Free Cash Flow | – | -$24M |
| Capital Spending | – | -$670K |
| FCF/Sales | – | -76.1% |
| CapEx/Sales | – | 2.1% |
Operational Efficiency
| Metric | ISPC | MXCT |
|---|---|---|
| Asset Turnover | – | 0.17x |
| Receivables Turnover | – | 7.9x |
| Inventory Turnover | – | 0.8x |
| Fixed Assets Turnover | – | 2.1x |
| Days Sales Outstanding | – | 46 days |
| Days Inventory | – | 441 days |
| Payables Period | 2089 days | 98 days |
| Cash Conversion Cycle | – | 389 days |
Income Statement
| Metric | ISPC | MXCT |
|---|---|---|
| Total Revenue | – | $31M |
| Operating Income | -$9M | -$42M |
| Net Income | – | -$36M |
| R&D Expense | – | $17M |
| SG&A Expense | $5M | $47M |
| Cost of Goods Sold | $820K | $6M |
Dividend & Shareholder Information
| Metric | ISPC | MXCT |
|---|---|---|
| Shares Outstanding | 3M | 103M |
ISPC vs MXCT: stock comparison and AI forecast
Which is bigger, ISPC or MXCT?
MXCT is 63.7 times larger than ISPC by market capitalization ($130M against $2M).
Which one does Intratio's AI model rank higher, ISPC or MXCT?
Intratio's model scores both stocks every trading day. Sign in to see their current direction; the exact ratings and forecasts come with a plan or a free follow slot.
This analysis is generated automatically using our proprietary AI systems and should not be considered personalized investment advice. Past performance does not guarantee future results. Always conduct your own research and consider consulting a financial advisor before making investment decisions.